The Clorox Company Earnings Call Transcripts
Fiscal Year 2026
-
ERP implementation is complete, setting the stage for improved execution and innovation. Category growth is expected to remain flat to 1%, with strong innovation and the GOJO acquisition driving future momentum. Margin expansion and productivity gains are anticipated, with deleveraging and disciplined capital allocation in focus.
-
Digital transformation and portfolio modernization have rebuilt margins and positioned for growth. Consumer insights drive innovation, with new platforms like Clorox Pure and Scentiva expanding reach. The GOJO acquisition will boost Health and Hygiene, supporting long-term profitable growth.
-
Q2 results met expectations amid macro and ERP challenges, with sequential improvement and reaffirmed guidance. Innovation and the GOJO acquisition are set to drive growth, while gross margin is expected to expand in the back half as cost savings materialize.
-
The acquisition of Gojo Industries and Purell for $2.25B strengthens leadership in health and hygiene, leveraging complementary B2B and retail strengths. Expected synergies, disciplined integration, and strong brand equity position the company for sustained growth and profitability.
-
ERP system launch completed, driving operational improvements despite Q1 challenges. Innovation and targeted investments are expected to support back-half growth and market share recovery, with gross margin expansion anticipated.
Fiscal Year 2025
-
U.S. consumers are value-focused, driving flat category growth, while innovation and digital investments are set to boost performance. Margin management, targeted investments, and a strong brand pipeline support confidence in growth and profitability for the coming years.
-
Margin and earnings outperformed expectations despite sales challenges, as digital transformation and ERP implementation progressed. Innovation is accelerating with new platforms and AI-driven insights, while brand superiority and strategic promotions are key to regaining share. ERP-related sales declines are temporary, with sequential improvement and margin expansion expected in the back half.
-
Fiscal 2025 saw strong margins but weak organic sales, with ERP-related inventory builds distorting results. Fiscal 2026 guidance calls for flat to modest organic growth and margin expansion, with improvement expected in the back half as innovation ramps up and ERP benefits materialize.
-
Consumer value-seeking and tariff-driven volatility have impacted category growth, but essentials remain resilient. Digital and margin transformation, including a major ERP rollout, are set to drive future productivity, with most benefits expected in FY27-28. Innovation and disciplined capital allocation underpin long-term growth.
-
Gross margin expanded for the 10th straight quarter despite weaker consumer sentiment and volatile sales. Q4 will see ERP-driven inventory build and tariff impacts, but stable margins and strong brand performance are expected.
-
A comprehensive digital and operational transformation has positioned the company for sustained growth, with strong innovation, personalization, and margin management driving superior consumer experiences and financial performance. Leadership transition supports continued execution.
-
Leadership transition to new CFO, ERP implementation, and full Glad control mark a transformative year. Q2 organic sales outperformed guidance, gross margin recovery on track, and long-term growth targets reaffirmed despite ongoing competitive and macro challenges.
-
Q1 delivered strong organic sales and gross margin growth, with full restoration of market share and supply post-cyberattack. Guidance for FY25 remains at 4% organic growth, with gross margin expected to return to pre-pandemic levels. Promotional activity and consumer value-seeking continue to shape the outlook.
Fiscal Year 2024
-
The meeting covered board elections, strong financial recovery post-cyber attack, and strategic progress on cost savings, innovation, and digital transformation. All proposals passed with high approval, and the dividend was increased. Inflation has normalized, and the company remains focused on resilience.
-
Management highlighted recovery from a cyberattack, portfolio optimization, and ongoing digital transformation. Growth targets remain at 3%-5%, supported by innovation, divestitures, and a focus on core brands. Market share is rebounding, with stronger growth expected in the second half of fiscal 2025.
-
Operational recovery and margin expansion marked FY24, with full supply restoration and most market share regained post-cyberattack. FY25 guidance targets 3%-5% organic sales growth, margin rebuilding, and strong free cash flow, supported by portfolio optimization and disciplined capital allocation.
-
Inventory and distribution have largely recovered post-cyberattack, with full restoration expected by fiscal year-end. Financial performance is ahead of expectations, margin expansion continues, and digital transformation—including AI-driven innovation—remains a key focus.